Posted on by lowes1

A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218)

Condition:   Asthma
Intervention:   Biological: RV16UB
Sponsors:   Merck;   Merck;   U-BIOPRED Consortium
Not yet recruiting – verified May 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.